SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-007389
Filing Date
2019-03-12
Accepted
2019-03-12 17:01:52
Documents
97
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cara-10k_20181231.htm 10-K 4368124
2 EX-10.11 cara-ex1011_720.htm EX-10.11 173478
3 EX-10.14 cara-ex1014_721.htm EX-10.14 251913
4 EX-23.1 cara-ex231_49.htm EX-23.1 7578
5 EX-31.1 cara-ex311_50.htm EX-31.1 15130
6 EX-31.2 cara-ex312_51.htm EX-31.2 15119
7 EX-32.1 cara-ex321_52.htm EX-32.1 9393
8 GRAPHIC gycnebnsgta5000001.jpg GRAPHIC 17662
  Complete submission text file 0001564590-19-007389.txt   13881443

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT cara-20181231.xml EX-101.INS 2972554
10 XBRL TAXONOMY EXTENSION SCHEMA cara-20181231.xsd EX-101.SCH 73243
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20181231_cal.xml EX-101.CAL 70891
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20181231_def.xml EX-101.DEF 314260
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20181231_lab.xml EX-101.LAB 556369
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20181231_pre.xml EX-101.PRE 491498
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36279 | Film No.: 19675788
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences